Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination

2003 ◽  
Vol 39 (3) ◽  
pp. 397-404 ◽  
Author(s):  
Carl Albrecht Schirren ◽  
Reinhart Zachoval ◽  
Joern Tilman Gerlach ◽  
Axel Ulsenheimer ◽  
Norbert Hubert Gruener ◽  
...  
2001 ◽  
Vol 183 (8) ◽  
pp. 1187-1194 ◽  
Author(s):  
Carl Albrecht Schirren ◽  
Maria‐Christina Jung ◽  
Thomas Worzfeld ◽  
Maxim Mamin ◽  
Gustavo Baretton ◽  
...  

2006 ◽  
Vol 44 ◽  
pp. S167 ◽  
Author(s):  
L. Weseslindtner ◽  
J.H. Aberle ◽  
C. Gurguta ◽  
P. Steindl-Munda ◽  
T. Popow-Kraupp ◽  
...  

1998 ◽  
Vol 28 ◽  
pp. 44
Author(s):  
J.T. Gerlach ◽  
H.M. Diepolder ◽  
N.H. Grüner ◽  
M.C. Jung ◽  
R. Zachoval ◽  
...  

2009 ◽  
Vol 24 (5) ◽  
pp. 701-708 ◽  
Author(s):  
Koji Hashimoto ◽  
Charles Miller ◽  
Kenzo Hirose ◽  
Teresa Diago ◽  
Federico Aucejo ◽  
...  

1999 ◽  
Vol 117 (4) ◽  
pp. 933-941 ◽  
Author(s):  
J.Tilman Gerlach ◽  
Helmut M. Diepolder ◽  
Maria–Christina Jung ◽  
Norbert H. Gruener ◽  
Winfried W. Schraut ◽  
...  

2013 ◽  
Vol 26 (3) ◽  
pp. 216-219
Author(s):  
Charlotte H.S.B. van den Berg ◽  
Nening M. Nanlohy ◽  
Thijs J.W. van de Laar ◽  
Maria Prins ◽  
Debbie van Baarle

2000 ◽  
Vol 32 ◽  
pp. 89
Author(s):  
N.H. Gruener ◽  
M.C. Jung ◽  
H.M. Diepolder ◽  
J.T. Gerlach ◽  
R. Zachoval ◽  
...  

2005 ◽  
Vol 79 (11) ◽  
pp. 6976-6983 ◽  
Author(s):  
Kazushi Sugimoto ◽  
David E. Kaplan ◽  
Fusao Ikeda ◽  
Jin Ding ◽  
Jonathan Schwartz ◽  
...  

ABSTRACT Hepatitis C virus (HCV) frequently persists with an apparently ineffective antiviral T-cell response. We hypothesized that some patients may be exposed to multiple HCV subtypes and that strain-specific T cells could contribute to the viral dynamics in this setting. To test this hypothesis, CD4 T-cell responses to three genotype 1a-derived HCV antigens and HCV antibody serotype were examined in chronically HCV infected (genotypes 1a, 1b, 2, 3, and 4) and spontaneously HCV recovered subjects. Consistent with multiple HCV exposure, 63% of patients infected with genotypes 2 to 4 (genotypes 2-4) and 36% of those infected with genotype 1b displayed CD4 T-cell responses to 1a-derived HCV antigens, while 29% of genotype 2-4-infected patients showed serotype responses to genotype 1. Detection of 1a-specific T cells in patients without active 1a infection suggested prior self-limited 1a infection with T-cell-mediated protection from 1a but not from non-1a viruses. Remarkably, CD4 T-cell responses to 1a-derived HCV antigens were weakest in patients with homologous 1a infection and greater in non-1a-infected patients: proportions of patients responding were 19% (1a), 36% (1b), and 63% (2-4) (P = 0.0006). Increased 1a-specific CD4 T-cell responsiveness in non-1a-infected patients was not due to increased immunogenicity or cross-reactivity of non-1a viruses but directly related to sequence divergence. We conclude that the T-cell response to the circulating virus is either suppressed or not induced in a strain-specific manner in chronically HCV infected patients and that, despite their ability to clear one HCV strain, patients may be reinfected with a heterologous strain that can then persist. These findings provide new insights into host-virus interactions in HCV infection that have implications for vaccine development.


Sign in / Sign up

Export Citation Format

Share Document